Innocoll Holdings plc
Healthcare · Pharmaceutical Preparations · L2 · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
FDA-approved drugs
openFDA · most recent- POSIMIRFeb 1, 2021
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsJul 24, 2017
- Shareholder vote · Other material eventJun 28, 2017
- Entered a material agreement · New financial obligationMay 10, 2017
- Entered a material agreement · Director / officer changeMay 3, 2017
- Entered a material agreementApr 6, 2017
- Other material eventMar 29, 2017
- Results of operationsMar 16, 2017
- Regulation FD disclosure · Other material eventMar 16, 2017
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFEBRUARY 14, 2018Feb 14, 2018
- SC 13G/AFeb 7, 2018
- SC 13D/ASCHEDULE 13D/AAug 8, 2017
- 4FORM 4 SUBMISSIONAug 7, 2017
- 15-12BAug 3, 2017
- SC 13D/AJul 31, 2017
- 4FORM 4Jul 28, 2017
- 4OWNERSHIP DOCUMENTJul 26, 2017
- 4OWNERSHIP DOCUMENTJul 26, 2017
- 4OWNERSHIP DOCUMENTJul 26, 2017
- 4OWNERSHIP DOCUMENTJul 26, 2017
- 4OWNERSHIP DOCUMENTJul 26, 2017
- 4OWNERSHIP DOCUMENTJul 26, 2017
- 4OWNERSHIP DOCUMENTJul 26, 2017
- 4OWNERSHIP DOCUMENTJul 26, 2017